Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07509996

Risk Factors Affecting Growth in Thalassemic Children at AUCH

The Effect of Different Risk Factors on Growth Parameters of Thalassemic Patients in Assiut University Children Hospital

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
85 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
12 Months – 18 Years
Healthy volunteers

Summary

Thalassemia major is a hereditary hemoglobinopathy characterized by ineffective erythropoiesis and severe anemia, necessitating lifelong blood transfusions(1,2). Regular transfusions lead to iron overload, a primary driver of growth retardation in affected children. Iron accumulation in tissues like the pituitary and liver disrupts growth hormone secretion and insulin-like growth factor-1 production.

Conditions

Interventions

TypeNameDescription
OTHERNon-interventional assessment of growth and risk factors in thalassemic childrenNo therapeutic intervention is applied. The study involves only observational assessment of clinical history, anthropometric measurements, laboratory investigations, and growth parameters in thalassemic children. This distinguishes it from interventional studies.

Timeline

Start date
2026-04-01
Primary completion
2027-04-01
Completion
2027-05-01
First posted
2026-04-03
Last updated
2026-04-03

Source: ClinicalTrials.gov record NCT07509996. Inclusion in this directory is not an endorsement.

Risk Factors Affecting Growth in Thalassemic Children at AUCH (NCT07509996) · Clinical Trials Directory